By that logic, every single publicly traded company would have massive short interest the way that Northwest bio does. Is that the case? No, this is not your normal situation. There is far more going on here than just an option covering with short interest. There's a lot of money at stake on the short side, and people who short stocks professionally usually do far more due diligence than your average retail investor.
News 
Market Data 
Discover 
AI
